Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore
· Delayed Price · Currency is SGD · Price in USD 3.230
+0.060 (1.89%)
At close: Dec 5, 2025
SGX:T14 Market Cap
SGX:T14 has a market cap or net worth of 5.70 billion as of December 5, 2025. Its market cap has increased by 33.41% in one year.
Market Cap
5.70B
Enterprise Value
5.39B
Revenue
972.89M
Ranking
n/a
PE Ratio
8.78
Stock Price
3.23
Market Cap Chart
Since June 6, 2001, SGX:T14's market cap has increased from 1.52B to 5.70B, an increase of 275.99%. That is a compound annual growth rate of 5.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haw Par Corporation | 3.46B |
| Raffles Medical Group | 1.83B |
| Thomson Medical Group | 1.53B |
| Riverstone Holdings | 1.27B |
| Q & M Dental Group (Singapore) | 486.44M |
| Vicplas International | 49.57M |
| Cordlife Group | 37.42M |